NGL Fine-Chem Limited (BOM:524774)
India · Delayed Price · Currency is INR 2,655.75
+29.40 (1.12%)
At close: Oct 22, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 16.41 billion as of October 22, 2026. It is the 21,529th most valuable company in the world and the 1,329th biggest in India. Its market cap has increased by 78.33% in one year.
Market Cap
16.41B
Enterprise Value
17.19B
Revenue
5.36B
Global Rank
Country Rank
#1,329 India
PE Ratio
28.64
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 16.41B, an increase of 20,307.07%. That is a compound annual growth rate of 27.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 16.41B | 88.48% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 165.26B |
| Suven Life Sciences | 78.68B |
| Symbiotec Pharmalab | 77.31B |
| IOL Chemicals and Pharmaceuticals | 51.25B |
| Gujarat Themis Biosyn | 45.72B |
| Bajaj HealthCare | 10.97B |
| Shree Ganesh Remedies | 8.38B |
| Influx Healthtech | 6.08B |